{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:53:19Z","timestamp":1787161999300,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01725-2","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:05:44Z","timestamp":1743199544000},"page":"3407-3426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Drug repurposing through Biophysical Insights: Focus on Indoleamine 2,3-Dioxygenase and Tryptophan 2,3-Dioxygenase Dual Inhibitors"],"prefix":"10.1007","volume":"83","author":[{"given":"Priyanga","family":"Paranthaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramanathan","family":"Karuppasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanthi","family":"Veerappapillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"1725_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.919072","volume":"12","author":"C Luo","year":"2022","unstructured":"Luo, C., Wang, P., He, S., Zhu, J., Shi, Y., & Wang, J. (2022). Progress and prospect of immunotherapy for triple-negative breast cancer. Frontiers in Oncology, 12, 919072.","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"1725_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00468-0","volume":"8","author":"P Zagami","year":"2022","unstructured":"Zagami, P., & Carey, L. A. (2022). Triple negative breast cancer: Pitfalls and progress. NPJ Breast Cancer, 8(1), 95.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"1725_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/cancers15010321","volume":"15","author":"L Li","year":"2023","unstructured":"Li, L., Zhang, F., Liu, Z., & Fan, Z. (2023). Immunotherapy for triple-negative breast cancer: Combination strategies to improve outcome. Cancers, 15(1), 321.","journal-title":"Cancers"},{"key":"1725_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphy.2024.1342115","volume":"12","author":"P Paranthaman","year":"2024","unstructured":"Paranthaman, P., & Veerappapillai, S. (2024). Tackling suppressive cancer microenvironment by NARF-derived immune modulatory vaccine and its validation using simulation strategies. Frontiers of Physics, 12, 1342115.","journal-title":"Frontiers of Physics"},{"issue":"11","key":"1725_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s12032-023-02183-7","volume":"40","author":"HNR Krishnamoorthy","year":"2023","unstructured":"Krishnamoorthy, H. N. R., & Karuppasamy, R. (2023). A multitier virtual screening of antagonists targeting PD-1\/PD-L1 interface for the management of triple-negative breast cancer. Medicine and Oncology, 40(11), 312.","journal-title":"Medicine and Oncology"},{"key":"1725_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107746","volume":"221","author":"A Dol\u0161ak","year":"2021","unstructured":"Dol\u0161ak, A., Gobec, S., & Sova, M. (2021). Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets. Pharmacology and Therapeutics, 221, 107746.","journal-title":"Pharmacology and Therapeutics"},{"key":"1725_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2024.2332509","volume":"24","author":"P Paranthaman","year":"2025","unstructured":"Paranthaman, P., & Veerappapillai, S. (2025). Identification of putative Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO) dual inhibitors for triple-negative breast cancer therapy. Journal of Biomolecular Structure and Dynamics, 24, 1\u201319.","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"issue":"23","key":"1725_CR8","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.3390\/molecules24234346","volume":"24","author":"S Sari","year":"2019","unstructured":"Sari, S., Tomek, P., Leung, E., & Reynisson, J. (2019). Discovery and characterisation of dual inhibitors of tryptophan 2,3-dioxygenase (TDO2) and indoleamine 2,3-dioxygenase 1 (IDO1) using virtual screening. Molecules, 24(23), 4346.","journal-title":"Molecules"},{"key":"1725_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3389\/fimmu.2014.00673","volume":"5","author":"M Platten","year":"2015","unstructured":"Platten, M., von Knebel Doeberitz, N., Oezen, I., Wick, W., & Ochs, K. (2015). Cancer immunotherapy by targeting IDO1\/TDO and their downstream effectors. Frontiers in Immunology, 5, 673.","journal-title":"Frontiers in Immunology"},{"key":"1725_CR10","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.2147\/DDDT.S373780","volume":"16","author":"X Peng","year":"2022","unstructured":"Peng, X., Zhao, Z., Liu, L., Bai, L., Tong, R., Yang, H., & Zhong, L. (2022). Targeting indoleamine dioxygenase and tryptophan dioxygenase in cancer immunotherapy: clinical progress and challenges. Drug Design, Development and Therapy, 16, 2639\u20132657.","journal-title":"Drug Design, Development and Therapy"},{"issue":"4","key":"1725_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1021\/acsmedchemlett.0c00004","volume":"11","author":"BT Parr","year":"2020","unstructured":"Parr, B. T., Pastor, R., Sellers, B. D., Pei, Z., Jaipuri, F. A., Castanedo, G. M., Gazzard, L., Kumar, S., Li, X., Liu, W., & Mendonca, R. (2020). Implementation of the CYP index for the design of selective tryptophan-2,3-dioxygenase inhibitors. ACS Medicinal Chemistry Letters, 11(4), 541\u2013549.","journal-title":"ACS Medicinal Chemistry Letters"},{"issue":"8","key":"1725_CR12","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1111\/bcp.13961","volume":"85","author":"S Ma","year":"2019","unstructured":"Ma, S., Suchomel, J., Yanez, E., Yost, E., Liang, X., Zhu, R., Le, H., Siebers, N., Joas, L., Morley, R., & Royer\u2010Joo, S. (2019). Investigation of the absolute bioavailability and human mass balance of navoximod, a novel IDO1 inhibitor. British Journal of Clinical Pharmacology, 85(8), 1751\u20131760.","journal-title":"British Journal of Clinical Pharmacology"},{"key":"1725_CR13","doi-asserted-by":"publisher","first-page":"e14228","DOI":"10.1200\/JCO.2019.37.15_suppl.e14228","volume":"37","author":"C Kim","year":"2019","unstructured":"Kim, C., Kim, J. H., Kim, J. S., Chon, H. J., & Kim, J. H. (2019). A novel dual inhibitor of IDO and TDO, CMG017, potently suppresses the kynurenine pathway and overcomes resistance to immune checkpoint inhibitors. Journal of Clinical Oncology, 37, e14228\u2013e14228.","journal-title":"Journal of Clinical Oncology"},{"key":"1725_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/11786469221138456","volume":"15","author":"S Yoshioka","year":"2022","unstructured":"Yoshioka, S., Ikeda, T., Fukuchi, S., Kawai, Y., Ohta, K., Murakami, H., Ogo, N., Muraoka, D., Takikawa, O., & Asai, A. (2022). Identification and characterization of a novel dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase. International Journal of Tryptophan Research: IJTR, 15, 11786469221138456.","journal-title":"International Journal of Tryptophan Research: IJTR"},{"key":"1725_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2024.2329302","volume":"18","author":"N Hanif","year":"2024","unstructured":"Hanif, N., & Sari, S. (2024). Discovery of novel IDO1\/TDO2 dual inhibitors: a consensus virtual screening approach with molecular dynamics simulations, and binding free energy analysis. Journal of Biomolecular Structure & Dynamics, 18, 1\u201317.","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"issue":"12","key":"1725_CR16","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nsb1203-980","volume":"10","author":"H Berman","year":"2003","unstructured":"Berman, H., Henrick, K., & Nakamura, H. (2003). Announcing the worldwide protein data bank. Nature Structural & Molecular Biology, 10(12), 980.","journal-title":"Nature Structural & Molecular Biology"},{"issue":"3","key":"1725_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221\u2013234.","journal-title":"Journal of Computer-Aided Molecular Design"},{"issue":"3","key":"1725_CR18","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1021\/acs.jctc.8b01026","volume":"15","author":"K Roos","year":"2019","unstructured":"Roos, K., Wu, C., Damm, W., Reboul, M., Stevenson, J. M., Lu, C., Dahlgren, M. K., Mondal, S., Chen, W., Wang, L., & Abel, R. (2019). OPLS3e: Extending force field coverage for drug-like small molecules. Journal of Chemical Theory and Computation, 15(3), 1863\u20131874.","journal-title":"Journal of Chemical Theory and Computation"},{"issue":"6","key":"1725_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1021\/acs.chemrestox.3c00352","volume":"37","author":"AMB Amorim","year":"2023","unstructured":"Amorim, A. M. B., Piochi, L. F., Gaspar, A. T., Preto, A. J., Ros\u00e1rio-Ferreira, N., & Moreira, I. S. (2023). Advancing drug safety in drug development: Bridging computational predictions for enhanced toxicity prediction. Chemical Research in Toxicology, 37(6), 827\u2013849.","journal-title":"Chemical Research in Toxicology"},{"issue":"21","key":"1725_CR20","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177\u20136196.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"16","key":"1725_CR21","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1021\/jm060522a","volume":"49","author":"PD Lyne","year":"2006","unstructured":"Lyne, P. D., Lamb, M. L., & Saeh, J. C. (2006). Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. Journal of Medicinal Chemistry, 49(16), 4805\u20134808.","journal-title":"Journal of Medicinal Chemistry"},{"key":"1725_CR22","doi-asserted-by":"publisher","first-page":"BBI","DOI":"10.4137\/BBI.S40427","volume":"10","author":"S Borkotoky","year":"2016","unstructured":"Borkotoky, S., Meena, C. K., & Murali, A. (2016). Interaction analysis of T7 RNA polymerase with heparin and its low molecular weight derivatives - An in silico approach. Bioinformatics and Biology Insights, 10, BBI\u2013S40427.","journal-title":"Bioinformatics and Biology Insights"},{"issue":"1","key":"1725_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep46710","volume":"7","author":"M W\u00f3jcikowski","year":"2017","unstructured":"W\u00f3jcikowski, M., Ballester, P. J., & Siedlecki, P. (2017). Performance of machine-learning scoring functions in structure-based virtual screening. Scientific Reports, 7(1), 46710.","journal-title":"Scientific Reports"},{"key":"1725_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ddtec.2020.09.001","volume":"32","author":"PJ Ballester","year":"2019","unstructured":"Ballester, P. J. (2019). Selecting machine-learning scoring functions for structure-based virtual screening. Drug Discovery Today: Technologies, 32, 81\u201387.","journal-title":"Drug Discovery Today: Technologies"},{"issue":"1","key":"1725_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/cbdd.12423","volume":"85","author":"JD Durrant","year":"2015","unstructured":"Durrant, J. D., & Amaro, R. E. (2015). Machine-learning techniques applied to antibacterial drug discovery. Chemical Biology & Drug Design, 85(1), 14\u201321.","journal-title":"Chemical Biology & Drug Design"},{"issue":"2","key":"1725_CR26","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1021\/acsomega.0c04672","volume":"6","author":"M Erguven","year":"2021","unstructured":"Erguven, M., Karakulak, T., Diril, M. K., & Karaca, E. (2021). How far are we from the rapid prediction of drug resistance arising due to kinase mutations? ACS Omega, 6(2), 1254\u20131265.","journal-title":"ACS Omega"},{"key":"1725_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2023.107850","volume":"104","author":"JM Abduljalil","year":"2023","unstructured":"Abduljalil, J. M., Elfiky, A. A., Sayed, E. S. T. A., & AlKhazindar, M. M. (2023). Computational identification of drug-like marine natural products as potential RNA polymerase inhibitors against Nipah virus. Computational Biology and Chemistry, 104, 107850.","journal-title":"Computational Biology and Chemistry"},{"issue":"9","key":"1725_CR28","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/bioinformatics\/btq112","volume":"26","author":"PJ Ballester","year":"2010","unstructured":"Ballester, P. J., & Mitchell, J. B. O. (2010). A machine learning approach to predicting protein-ligand binding affinity with applications to molecular docking. Bioinformatics, 26(9), 1169\u20131175.","journal-title":"Bioinformatics"},{"issue":"11","key":"1725_CR29","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1021\/ci2003889","volume":"51","author":"JD Durrant","year":"2011","unstructured":"Durrant, J. D., & Mccammon, J. A. (2011). NNScore 2.0: A neural-network receptor \u00e0 ligand scoring function. Journal of Chemical Information and Modeling, 51(11), 2897\u20132903.","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"2","key":"1725_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1021\/acs.jcim.7b00650","volume":"58","author":"J Jim\u00e9nez","year":"2018","unstructured":"Jim\u00e9nez, J., \u0160kali\u010d, M., Mart\u00ednez-Rosell, G., & De Fabritiis, G. (2018). KDEEP: Protein-ligand absolute binding affinity prediction via 3D-convolutional neural networks. Journal of Chemical Information and Modeling, 58(2), 287\u2013296.","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"1","key":"1725_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-021-00522-2","volume":"13","author":"AT McNutt","year":"2021","unstructured":"McNutt, A. T., Francoeur, P., Aggarwal, R., Masuda, T., Meli, R., Ragoza, M., & Koes, D. R. (2021). GNINA 1.0: molecular docking with deep learning. Journal of Cheminformatics, 13(1), 43.","journal-title":"Journal of Cheminformatics"},{"issue":"W1","key":"1725_CR32","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee, P., Eckert, A. O., Schrey, A. K., & Preissner, R. (2018). ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 46(W1), W257\u2013W263.","journal-title":"Nucleic Acids Research"},{"issue":"W1","key":"1725_CR33","doi-asserted-by":"publisher","first-page":"W502","DOI":"10.1093\/nar\/gkaa327","volume":"48","author":"J Cadow","year":"2021","unstructured":"Cadow, J., Born, J., Manica, M. M., Oskooei, A., & Mart\u00ednez, M. R. (2021). PaccMann: a web service for interpretable anticancer compound sensitivity prediction. Nucleic Acids Research, 48(W1), W502\u2013W508.","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"1725_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/07391102.2015.1134346","volume":"35","author":"FI Khan","year":"2017","unstructured":"Khan, F. I., Aamir, M., Wei, D.-Q., Ahmad, F., & Hassan, M. I. (2017). Molecular mechanism of Ras-related protein Rab-5A and effect of mutations in the catalytically active phosphate-binding loop. Journal of Biomolecular Structure & Dynamics, 35(1), 105\u2013118.","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"issue":"25","key":"1725_CR35","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jcc.23354","volume":"34","author":"J Huang","year":"2013","unstructured":"Huang, J., & MacKerell, A. D. J. (2013). CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. Journal of Computational Chemistry, 34(25), 2135\u20132145.","journal-title":"Journal of Computational Chemistry"},{"issue":"2","key":"1725_CR36","doi-asserted-by":"publisher","first-page":"24503","DOI":"10.1063\/1.2136877","volume":"124","author":"Y Wu","year":"2006","unstructured":"Wu, Y., Tepper, H. L., & Voth, G. A. (2006). Flexible simple point-charge water model with improved liquid-state properties. The Journal of Chemical Physics, 124(2), 24503.","journal-title":"The Journal of Chemical Physics"},{"issue":"1","key":"1725_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-022-01924-4","volume":"40","author":"P Ramesh","year":"2022","unstructured":"Ramesh, P., Karuppasamy, R., & Veerappapillai, S. (2022). Machine learning driven drug repurposing strategy for identification of potential RET inhibitors against non-small cell lung cancer. Medical Oncology, 40(1), 56.","journal-title":"Medical Oncology"},{"issue":"9","key":"1725_CR38","first-page":"1085","volume":"23","author":"P Murali","year":"2023","unstructured":"Murali, P., & Karuppasamy, R. (2023). Imidazole and biphenyl derivatives as anti-cancer agents for glioma therapeutics: Computational drug repurposing strategy. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry \u2013 Anti-Cancer Agents), 23(9), 1085\u20131101.","journal-title":"Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry \u2013 Anti-Cancer Agents)"},{"issue":"4","key":"1725_CR39","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1021\/acs.jmedchem.0c01968","volume":"64","author":"UF R\u00f6hrig","year":"2021","unstructured":"R\u00f6hrig, U. F., Majjigapu, S. R., Reynaud, A., Pojer, F., Dilek, N., Reichenbach, P., & Zoete, V. (2021). Azole-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Journal of Medicinal Chemistry, 64(4), 2205\u20132227.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"16","key":"1725_CR40","first-page":"6265","volume":"39","author":"D Pratik","year":"2020","unstructured":"Pratik, D., Ranabir, M., Mahitosh, M., & Piyali, B. (2020). In-silico approach for identification of effective and stable inhibitors for COVID-19 main protease (M pro) from flavonoid based phytochemical constituents of Calendula officinali. Journal of Biomolecular Structure & Dynamics, 39(16), 6265\u20136280.","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"key":"1725_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphy.2024.1345834","volume":"12","author":"P Murali","year":"2024","unstructured":"Murali, P., & Karuppasamy, R. (2024). Exploring the potential of nutraceutical to combat gliomas: focus on mIDH2 protein. Frontiers of Physics, 12, 1345834.","journal-title":"Frontiers of Physics"},{"issue":"1","key":"1725_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-023-03859-7","volume":"14","author":"A Antony","year":"2024","unstructured":"Antony, A., Veerappapillai, S., & Karuppasamy, R. (2024). In-silico bioprospecting of secondary metabolites from endophytic Streptomyces spp. Against Magnaporthe oryzae, a cereal killer fungus. 3 Biotech, 14(1), 15.","journal-title":"3 Biotech"},{"issue":"1","key":"1725_CR43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/bib\/bbz173","volume":"22","author":"C Shen","year":"2021","unstructured":"Shen, C., Hu, Y., Wang, Z., Zhang, X., Zhong, H., Wang, G., Yao, X., Xu, L., Cao, D., & Hou, T. (2021). Can machine learning consistently improve the scoring power of classical scoring functions? Insights into the role of machine learning in scoring functions. Briefings in Bioinformatics, 22(1), 497\u2013514.","journal-title":"Briefings in Bioinformatics"},{"issue":"51","key":"1725_CR44","doi-asserted-by":"publisher","first-page":"47536","DOI":"10.1021\/acsomega.2c05693","volume":"7","author":"CN Cavasotto","year":"2022","unstructured":"Cavasotto, C. N., & Scardino, V. (2022). Machine learning toxicity prediction: Latest advances by toxicity end point. ACS Omega, 7(51), 47536\u201347546.","journal-title":"ACS Omega"},{"key":"1725_CR45","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1039\/C5MB00137D","volume":"11","author":"T Sindhu","year":"2015","unstructured":"Sindhu, T., & Srinivasan, P. (2015). Identification of potential dual agonists of FXR and TGR5 using e-pharmacophore based virtual screening. Molecular BioSystems, 11, 1305\u20131318.","journal-title":"Molecular BioSystems"},{"issue":"5","key":"1725_CR46","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.drudis.2014.11.007","volume":"20","author":"CJD Austin","year":"2015","unstructured":"Austin, C. J. D., & Rendina, L. M. (2015). Targeting key dioxygenases in tryptophan-kynurenine metabolism for immunomodulation and cancer chemotherapy. Drug Discovery Today, 20(5), 609\u2013617.","journal-title":"Drug Discovery Today"},{"key":"1725_CR47","doi-asserted-by":"crossref","unstructured":"Kumar, S., Waldo, J. P., Jaipuri, F. A., Marcinowicz, A., Van Allen, C., Adams, J., & Mautino, M. R. (2019). Discovery of clinical candidate (1 R,4 r)-4-((R)-2-((S)-6-Fluoro-5 H-imidazo[5,1-A[isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a potent and selective inhibitor of indoleamine 2,3-dioxygenase 1. Journal of Medicinal Chemistry, 62(14), 6705\u20136733.","DOI":"10.1021\/acs.jmedchem.9b00662"},{"key":"1725_CR48","doi-asserted-by":"publisher","first-page":"110821","DOI":"10.1016\/j.biopha.2020.110821","volume":"132","author":"J Zhou","year":"2020","unstructured":"Zhou, J., Zhu, J., Yu, S., Ma, H., Chen, J., Ding, X., Chen, G., Liang, Y., & Zhang, Q. (2020). Biomedicine & pharmacotherapy sodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK \/ mTOR pathway. Biomedicine and Pharmacotherapy, 132, 110821.","journal-title":"Biomedicine and Pharmacotherapy"},{"issue":"22","key":"1725_CR49","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1080\/14786419.2020.1739044","volume":"35","author":"QN Xu","year":"2021","unstructured":"Xu, Q. N., Zhu, D., Wang, G. H., Lin, T., Sun, C. L., Ding, R., Tian, W. J., & Chen, H. F. (2021). Phenolic glycosides and flavonoids with antioxidant and anticancer activities from Desmodium caudatum. Natural Product Research, 35(22), 4534\u20134541.","journal-title":"Natural Product Research"},{"issue":"7","key":"1725_CR50","first-page":"7679","volume":"9","author":"MT Thant","year":"2023","unstructured":"Thant, M. T., Bhummaphan, N., Wuttiin, J., Puttipanyalears, C., Chaichompoo, W., Rojsitthisak, P., Rojsitthisak, P., Punpreuk, Y., B\u00f6ttcher, C., Likhitwitayawuid, K., & Sritularak, B. (2023). New phenolic glycosides from Coelogyne fuscescens Lindl. var. brunnea and their cytotoxicity against human breast cancer cells. ACS Omega, 9(7), 7679\u20137691.","journal-title":"ACS Omega"},{"issue":"1","key":"1725_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01725-8","volume":"8","author":"A Lewis-Ballester","year":"2017","unstructured":"Lewis-Ballester, A., Pham, K. N., Batabyal, D., Karkashon, S., Bonanno, J. B., Poulos, T. L., & Yeh, S. R. (2017). Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase. Nature Communications, 8(1), 1693.","journal-title":"Nature Communications"},{"issue":"11","key":"1725_CR52","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.3390\/pharmaceutics13111775","volume":"13","author":"P Ramesh","year":"2021","unstructured":"Ramesh, P., Shin, W. H., & Veerappapillai, S. (2021). Discovery of a potent candidate for ret-specific non-small-cell lung cancer\u2014a combined in silico and in vitro strategy. Pharmaceutics, 13(11), 1775.","journal-title":"Pharmaceutics"},{"issue":"7","key":"1725_CR53","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1080\/07391102.2018.1468282","volume":"37","author":"T Mohammad","year":"2019","unstructured":"Mohammad, T., Khan, F. I., Lobb, K. A., Islam, A., Ahmad, F., & Hassan, M. I. (2019). Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4). Journal of Biomolecular Structure & Dynamics, 37(7), 1813\u20131829.","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"key":"1725_CR54","first-page":"1","volume":"16","author":"A Khan","year":"2024","unstructured":"Khan, A., Zahid, M. A., Shahab, M., Al-Zoubi, R. M., Shkoor, M., Benameur, T., & Agouni, A. (2024). Investigating the role of functional mutations in leucine binding to Sestrin2 in aging and age-associated degenerative pathologies using structural and molecular simulation approaches. Journal of Biomolecular Structure & Dynamics, 16, 1\u20133.","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"issue":"3","key":"1725_CR55","doi-asserted-by":"publisher","first-page":"e0121415","DOI":"10.1371\/journal.pone.0121415","volume":"10","author":"J Maharana","year":"2015","unstructured":"Maharana, J., Sahoo, B. R., Bej, A., Jena, I., Parida, A., Sahoo, J. R., Dehury, B., Patra, M. C., Martha, S. R., Balabantray, S., & Pradhan, S. K. (2015). Structural models of zebrafish (Danio rerio) NOD1 and NOD2 NACHT domains suggest differential ATP binding orientations: insights from computational modeling, docking and molecular dynamics simulations. PLoS ONE, 10(3), e0121415.","journal-title":"PLoS ONE"},{"issue":"13","key":"1725_CR56","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1080\/07391102.2018.1520649","volume":"37","author":"R Kumar","year":"2019","unstructured":"Kumar, R., Bansal, A., Shukla, R., Raj Singh, T., Wasudeo Ramteke, P., Singh, S., & Gautam, B. (2019). In silico screening of deleterious single nucleotide polymorphisms (SNPs) and molecular dynamics simulation of disease associated mutations in gene responsible for oculocutaneous albinism type 6 (OCA 6) disorder. Journal of Biomolecular Structure & Dynamics, 37(13), 3513\u20133523.","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"issue":"6","key":"1725_CR57","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1142\/S2737416522500260","volume":"21","author":"P Murali","year":"2022","unstructured":"Murali, P., & Karuppasamy, R. (2022). Identification of novel mutant (R132H) isocitrate dehydrogenase 1 inhibitors for glioma therapy. Journal of Computational Biophysics and Chemistry, 21(6), 647\u2013661.","journal-title":"Journal of Computational Biophysics and Chemistry"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01725-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01725-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01725-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:32:27Z","timestamp":1757205147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01725-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1725"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01725-2","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"10 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}